Dad-turned-CEO inks Pfizer deal for Duchenne drugs

Ilan Ganot formed a drug development company, which is now looking into three initiatives to treat his 4-year-old son's disease, Duchenne muscular dystrophy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.